Management of obesity in advanced chronic liver disease - PubMed
a day ago
- #obesity
- #management
- #liver disease
- Obesity is a major global health challenge linked to metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction- and alcohol-associated liver disease (MetALD).
- Increased prevalence of obesity in patients with advanced chronic liver disease (ACLD) adversely impacts prognosis.
- Higher BMI is a modifiable risk factor for liver disease progression, regardless of the cause.
- New anti-obesity medications, alongside lifestyle changes and bariatric surgery, offer personalized management options for obesity-related liver disease.